Effect of plasmalogen -containing food on cognitive function in patients with Alzheimer disease - a single- blind trial
Not Applicable
- Conditions
- Alzheimer disease
- Registration Number
- JPRN-UMIN000009898
- Lead Sponsor
- Bioennet corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Those who have bird allergy 2.Those who were judged unqualified by the responsible doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link plasmalogen supplementation to cognitive improvement in Alzheimer disease?
How does plasmalogen-containing food compare to cholinesterase inhibitors in Alzheimer disease treatment efficacy?
Which biomarkers correlate with plasmalogen response in Alzheimer disease clinical trials?
What adverse events are associated with plasmalogen-rich dietary interventions in neurodegenerative disorders?
Are there synergistic effects of plasmalogens with Aβ-targeting therapies in Alzheimer disease progression?